These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 27238570)
1. EGF-stimulated activation of Rab35 regulates RUSC2-GIT2 complex formation to stabilize GIT2 during directional lung cancer cell migration. Duan B; Cui J; Sun S; Zheng J; Zhang Y; Ye B; Chen Y; Deng W; Du J; Zhu Y; Chen Y; Gu L Cancer Lett; 2016 Aug; 379(1):70-83. PubMed ID: 27238570 [TBL] [Abstract][Full Text] [Related]
2. Paxillin kinase linker (PKL) regulates Vav2 signaling during cell spreading and migration. Jones MC; Machida K; Mayer BJ; Turner CE Mol Biol Cell; 2013 Jun; 24(12):1882-94. PubMed ID: 23615439 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC. Che TF; Lin CW; Wu YY; Chen YJ; Han CL; Chang YL; Wu CT; Hsiao TH; Hong TM; Yang PC Oncotarget; 2015 Nov; 6(35):37349-66. PubMed ID: 26497368 [TBL] [Abstract][Full Text] [Related]
4. An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling. Lin PL; Wu TC; Wu DW; Wang L; Chen CY; Lee H Eur J Cancer; 2017 Nov; 85():95-105. PubMed ID: 28892778 [TBL] [Abstract][Full Text] [Related]
5. Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling. Zhong D; Ru Y; Wang Q; Zhang J; Zhang J; Wei J; Wu J; Yao L; Li X; Li X Cancer Lett; 2015 Apr; 359(1):57-64. PubMed ID: 25573345 [TBL] [Abstract][Full Text] [Related]
6. Rab35/ACAP2 and Rab35/RUSC2 Complex Structures Reveal Molecular Basis for Effector Recognition by Rab35 GTPase. Lin L; Shi Y; Wang M; Wang C; Zhu J; Zhang R Structure; 2019 May; 27(5):729-740.e3. PubMed ID: 30905672 [TBL] [Abstract][Full Text] [Related]
7. G-protein-coupled receptor-2-interacting protein-1 is required for endothelial cell directional migration and tumor angiogenesis via cortactin-dependent lamellipodia formation. Majumder S; Sowden MP; Gerber SA; Thomas T; Christie CK; Mohan A; Yin G; Lord EM; Berk BC; Pang J Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):419-26. PubMed ID: 24265417 [TBL] [Abstract][Full Text] [Related]
8. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression. Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326 [TBL] [Abstract][Full Text] [Related]
9. An ADP-ribosylation factor GTPase-activating protein Git2-short/KIAA0148 is involved in subcellular localization of paxillin and actin cytoskeletal organization. Mazaki Y; Hashimoto S; Okawa K; Tsubouchi A; Nakamura K; Yagi R; Yano H; Kondo A; Iwamatsu A; Mizoguchi A; Sabe H Mol Biol Cell; 2001 Mar; 12(3):645-62. PubMed ID: 11251077 [TBL] [Abstract][Full Text] [Related]
10. CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer. Yuan W; Liu B; Wang X; Li T; Xue H; Mo X; Yang S; Ding S; Han W Cancer Lett; 2017 Feb; 386():77-86. PubMed ID: 27867015 [TBL] [Abstract][Full Text] [Related]
11. Functional expression of the voltage-gated Na⁺-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells. Campbell TM; Main MJ; Fitzgerald EM J Cell Sci; 2013 Nov; 126(Pt 21):4939-49. PubMed ID: 23986482 [TBL] [Abstract][Full Text] [Related]
12. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174 [TBL] [Abstract][Full Text] [Related]
13. Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis. Ahn J; Truesdell P; Meens J; Kadish C; Yang X; Boag AH; Craig AW Mol Cancer Res; 2013 Aug; 11(8):952-63. PubMed ID: 23699534 [TBL] [Abstract][Full Text] [Related]
14. RCCD1 depletion attenuates TGF-β-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells. Wu J; He Z; Yang XM; Li KL; Wang DL; Sun FL Cancer Lett; 2017 Aug; 400():18-29. PubMed ID: 28455245 [TBL] [Abstract][Full Text] [Related]
15. Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer. Lin SY; Chang HH; Lai YH; Lin CH; Chen MH; Chang GC; Tsai MF; Chen JJ PLoS One; 2015; 10(5):e0123305. PubMed ID: 25955608 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration. Dise RS; Frey MR; Whitehead RH; Polk DB Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G276-85. PubMed ID: 17991704 [TBL] [Abstract][Full Text] [Related]
17. EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling. Tom EC; Mushtaq I; Mohapatra BC; Luan H; Bhat AM; Zutshi N; Chakraborty S; Islam N; Arya P; Bielecki TA; Iseka FM; Bhattacharyya S; Cypher LR; Goetz BT; Negi SK; Storck MD; Rana S; Barnekow A; Singh PK; Ying G; Guda C; Natarajan A; Band V; Band H Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932478 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells. Liu H; Hu X; Zhu Y; Jiang G; Chen S Tumour Biol; 2016 Jun; 37(6):7287-93. PubMed ID: 26666824 [TBL] [Abstract][Full Text] [Related]
19. Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression. Chang YC; Chan YC; Chang WM; Lin YF; Yang CJ; Su CY; Huang MS; Wu ATH; Hsiao M Cancer Lett; 2017 Sep; 403():28-36. PubMed ID: 28610954 [TBL] [Abstract][Full Text] [Related]
20. SRC promotes survival and invasion of lung cancers with epidermal growth factor receptor abnormalities and is a potential candidate for molecular-targeted therapy. Leung EL; Tam IY; Tin VP; Chua DT; Sihoe AD; Cheng LC; Ho JC; Chung LP; Wong MP Mol Cancer Res; 2009 Jun; 7(6):923-32. PubMed ID: 19491201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]